Your browser doesn't support javascript.
loading
Effect of qingyi decoction in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia / 中国中西医结合杂志
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 607-610, 2009.
Artigo em Chinês | WPRIM | ID: wpr-273615
ABSTRACT
<p><b>OBJECTIVE</b>To explore the preventive effect of Qingyi Decoction (QYD) on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and hyperamylasemia.</p><p><b>METHODS</b>One hundred and twenty-five patients scheduled to receive ERCP were randomized by the digital table into three groups, two were medicated respectively with QYD (39 cases) and octreotide (42 cases), the other one was untreated for control (44 cases). Changes of blood levels of amylase, C-reactive protein (CRP), and interleukin-10 (IL-10), as well as the incidence of pancreatitis and hyperamylasemia was observed and compared.</p><p><b>RESULTS</b>The 4 h and 24 h post-operational blood amylase (U/L) was 132.03 +/- 75.29 and 153.15 +/- 78.69 in the QYD group, and 134.74 +/- 22.24 and 148.50 +/- 79.37 in the octreotide group, all were significantly lower than those in the control group (241.27 +/- 137.04 and 286.89 +/- 133.77), respectively. The 24 h CRP (mg/L) in both QYD and octreotide group (11.05 +/- 3.57 and 12.48 +/- 3.80) was also lower than that in the control group (17.70 +/- 4.93, P < 0.05), while the 24 h IL-10 (ng/L) in the QYD group (105.00 +/- 31.85) was higher than that in the octreotide group (77.98 +/- 33.13) and the control group (75.98 +/- 30.99) respectively. The incidence of pancreatitis in the QYD, octreotide, and the control group was 2.6%, 0 and 11.4%, that of hyperamylasemia in them 28.2%, 21.4%, and 56.8%, respectively. The occurrence rate of hyperamylasemia was lower in the QYD group and the octreotide group than in the control group (P < 0.05).</p><p><b>CONCLUSION</b>QYD could lower CRP and up-regulate IL-10 level, restrain the inflammation reaction and reduce the blood amylase level in the post-ERCP period, thus reducing the incidence of hyperamylasemia.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Pancreatite / Sangue / Proteína C-Reativa / Medicamentos de Ervas Chinesas / Octreotida / Colangiopancreatografia Retrógrada Endoscópica / Interleucina-10 / Hiperamilassemia / Usos Terapêuticos / Amilases Tipo de estudo: Ensaio Clínico Controlado Limite: Adolescente / Adulto / Feminino / Humanos / Masculino Idioma: Chinês Revista: Chinese Journal of Integrated Traditional and Western Medicine Ano de publicação: 2009 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Pancreatite / Sangue / Proteína C-Reativa / Medicamentos de Ervas Chinesas / Octreotida / Colangiopancreatografia Retrógrada Endoscópica / Interleucina-10 / Hiperamilassemia / Usos Terapêuticos / Amilases Tipo de estudo: Ensaio Clínico Controlado Limite: Adolescente / Adulto / Feminino / Humanos / Masculino Idioma: Chinês Revista: Chinese Journal of Integrated Traditional and Western Medicine Ano de publicação: 2009 Tipo de documento: Artigo